Research Interest and Publications-Dr Shabir Ahmad Mir

Dr Shabir Ahmad Mir

Research Interest

1. Biochemistry and Molecular biology
2. Proteomics and Structural Biology
3. Infectious diseases and Immunology

Publications

1. Mir SA, Alaidarous M, Mir BA, Alshehri B, Dukhyil AAB, Banawas S, et al., (2022).  Identification of Mycobacterial RNA Polymerase inhibitors from the main phytochemicals of Nigella sativa: An in silico study. International Journal of Pharmacology, 14.  SCIE, Q4

2. Siddiqui S, Ahmad R, Alaidarous M, Zia Q, Mir SA, Alshehri B, et al., (2022).  Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach. Journal of Food Biochemistry, 00, e14062.  SCIE, Q3

3. Alsagaby SA, Aljouie A, Alshammari TH , Mir SA , Alhumaydhi FA , Abdulmonem WA et al., (2021). Haematological and radiological-based prognostic markers of COVID-19. Journal of Infection and Public Health, 14, 1650-1657.  SCIE, Q2  

4. Kinyoki1D, Osgood-Zimmerman AE, Bhattacharjee NV, Local Burden of Disease Anaemia Collaborators (Mir SA and others), Kassebaum NJ and Hay SI (2021). Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. Nature Medicine, 27(10):1761–1782.   SCIE Q1

5. Sidiq M, Alenazi W, Kashoo FZ,  Qasim M, Lopez MP, Ahmad M, Mani S, Shaphe MA, Khodairi O, Almutairi A, Mir SA (2021). Prevalence of non-specific chronic low-back pain and risk factors among male soldiers in Saudi Arabia. Peer, 9:e12249.  SCIE, Q2

6. Mir SA (2021). Structure and function of the important internalins of Listeria monocytogenes. Current protein and peptide Sciences, 22(8), 620-628. SCIE, Q3

7. Mir SA, Firoz A, Alaidarous M, Alshehri B, Dukhyil AA, Banawas S, Alsagaby SA, et al., (2022). Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach. Saudi Journal of Biological Sciences, 29(1):394-401. SCIE, Q2

8. Alqahtani SM, Alsagaby SA, Mir SA, Alaidarous M, Alshehri B, Dukhyil AA, et al., (2021). Seroprevalence of Viral Hepatitis B and C among Blood Donors in the Northern Region of Riyadh Province, Saudi Arabia. Healthcare 9(8), 934.  SCIE, Q2

9. Mir SA, Alshehri BM, Alaidarous A, et al., (2020) Prevalence of Hemoglobinopathies (β-thalassemia and sickle cell trait) in the Adult Population of Al Majma’ah, Saudi Arabia. Hemoglobin 44:1, 47-50.   SCIE, Q4

10. Mir SA, Sharma S. (2019). Immunotherapeutic potential of an N-formylated peptide of Listeria monocytogenes in experimental tuberculosis.Immunopharmacology and Immunotoxicology 41:2, 292-298.  SCIE, Q3

11. Alaidarous M, Choudhary RK, Waly MI, Mir S, Dukhyil AB, Saeed SS, Alshehri BM (2018). The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia. Journal of Infection and Public Health11:5, 702-706.  SCIE, Q2

12. Mir BA, Mir SA, Khazir J, Tonfack LB, Cowan DA, Vyas D, Koul S (2015). Cold stress affects antioxidative response and accumulation of medicinally important withanolides in Withaniasomnifera (L.) Dunal. Industrial Crops and Products 74, 1008-1016.  SCIE Q1

13. Mir SA, Verma I, Sharma S (2014). Immunotherapeutic potential of recombinant ESAT-6 protein in mouse model of experimental tuberculosis. Immunology letters 158, 88– 94. SCIE Q3

14. Mir SA, Sharma S (2014). Immunotherapeutic potential of N-formylated peptides of ESAT-6 and glutamine synthetase in experimental tuberculosis. International Immunopharmacology 18, 298-303.  SCIE Q2

15. Mir SA, Sharma S (2013). Role of MHC class Ib molecule, H2-M3 in host immunity against tuberculosis. Vaccine 31, 3818– 3825.  SCIE Q3